aluates Reports

$ 0.0

Automative

Global Targeted RNA Sequencing Market Research Report 2026

Published Date: 2026-01-23

Report Code: QYRE-Auto-37Z9008

Global Targeted RNA Sequencing Market Size Status and Forecast 2022

BUY CHAPTERS

Global Targeted RNA Sequencing Market Research Report 2026

Code: QYRE-Auto-37Z9008

Report

2026-01-23

Pages:115

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Thermo Fisher

Illumina Inc

Roche Holdings

LabCorp

Berry Genomics

Macrogen

Genewiz

Eurofins

BGI

Targeted RNA Sequencing Market Size

The global Targeted RNA Sequencing market was valued at US$ 2786 million in 2025 and is anticipated to reach US$ 9089 million by 2032, at a CAGR of 18.7% from 2026 to 2032.

Targeted RNA Sequencing Market

Targeted RNA Sequencing is a molecular biology technique that uses high-throughput sequencing to quantitatively analyze the expression of specific genes or gene regions. Unlike whole transcriptome sequencing, targeted RNA sequencing focuses on a defined gene panel, offering advantages such as lower cost, higher sensitivity, and simplified data processing. It is widely used in cancer subtyping, immune microenvironment profiling, drug target identification, genetic disease diagnostics, and single-cell expression analysis. With the proliferation of sequencing platforms and the advancement of multiplex PCR and probe hybridization technologies, targeted RNA sequencing has become a routine and powerful tool for clinical research institutions and biotech companies in the field of precision expression analysis.

As the concept of personalized treatment deepens and precision medicine advances, demand for targeted RNA sequencing continues to grow, especially in cancer and genetic disease applications. Government initiatives and sustained investments from pharma giants in biomarker development and bioinformatics are accelerating technology adoption in research labs and commercial institutions. Companies like Illumina and Thermo Fisher have reported a consistent CAGR of over 20% in targeted sequencing panel revenues, highlighting its growing role in genomic service portfolios. National funding surges in life sciences across the U.S., China, and Europe are further energizing the market.

Despite the promising outlook, the market faces challenges such as complex data interpretation, lack of standardization in workflows, and technical sensitivity to sample preparation. High-throughput sequencing platforms remain costly, creating adoption barriers for smaller labs and institutions. Additionally, increasingly stringent regulatory frameworks (e.g., IVD certifications, CLIA compliance) have extended timelines for clinical applications. Competitive pressure is also rising, with pricing becoming a pivotal factor and bargaining power concentrated among leading players.

Downstream demand is primarily driven by cancer research institutes, biopharma companies, and third-party CRO service providers. With the rise of cancer screening, liquid biopsy, and immunotherapy target development, the reliance on RNA-based companion diagnostics is intensifying. According to investment bank reports, targeted expression profiling is expanding its share within the RNA sequencing market and is expected to penetrate high-value segments such as solid tumor diagnostics, pediatric rare disease analysis, and quality control in cell therapy manufacturing over the next five years.

This report delivers a comprehensive overview of the global Targeted RNA Sequencing market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Targeted RNA Sequencing. The Targeted RNA Sequencing market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Targeted RNA Sequencing market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Targeted RNA Sequencing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Targeted RNA Sequencing Market Report

Report Metric	Details
Report Name	Targeted RNA Sequencing Market
Accounted market size in 2025	US$ 2786 million
Forecasted market size in 2032	US$ 9089 million
CAGR	18.7%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Exome Sequencing Enrichment Sequencing Amplicon Sequencing
Segment by Application	Research Institutes Hospitals & Clinics Biotechnology Company Diagnostic Lab
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, LabCorp, Berry Genomics, Macrogen, GENEWIZ, Natera, Novogen, Pacific Biosciences, Oxford Nanopore
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Targeted RNA Sequencing companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Targeted RNA Sequencing Market growing?

Ans: The Targeted RNA Sequencing Market witnessing a CAGR of 18.7% during the forecast period 2026-2032.

What is the Targeted RNA Sequencing Market size in 2032?

Ans: The Targeted RNA Sequencing Market size in 2032 will be US$ 9089 million.

Who are the main players in the Targeted RNA Sequencing Market report?

Ans: The main players in the Targeted RNA Sequencing Market are Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, LabCorp, Berry Genomics, Macrogen, GENEWIZ, Natera, Novogen, Pacific Biosciences, Oxford Nanopore

What are the Application segmentation covered in the Targeted RNA Sequencing Market report?

Ans: The Applications covered in the Targeted RNA Sequencing Market report are Research Institutes, Hospitals & Clinics, Biotechnology Company, Diagnostic Lab

What are the Type segmentation covered in the Targeted RNA Sequencing Market report?

Ans: The Types covered in the Targeted RNA Sequencing Market report are Exome Sequencing, Enrichment Sequencing, Amplicon Sequencing

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Targeted RNA Sequencing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Exome Sequencing

1.2.3 Enrichment Sequencing

1.2.4 Amplicon Sequencing

1.3 Market by Application

1.3.1 Global Targeted RNA Sequencing Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Research Institutes

1.3.3 Hospitals & Clinics

1.3.4 Biotechnology Company

1.3.5 Diagnostic Lab

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Targeted RNA Sequencing Market Perspective (2021–2032)

2.2 Global Targeted RNA Sequencing Growth Trends by Region

2.2.1 Global Targeted RNA Sequencing Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Targeted RNA Sequencing Historic Market Size by Region (2021–2026)

2.2.3 Targeted RNA Sequencing Forecasted Market Size by Region (2027–2032)

2.3 Targeted RNA Sequencing Market Dynamics

2.3.1 Targeted RNA Sequencing Industry Trends

2.3.2 Targeted RNA Sequencing Market Drivers

2.3.3 Targeted RNA Sequencing Market Challenges

2.3.4 Targeted RNA Sequencing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Targeted RNA Sequencing Players by Revenue

3.1.1 Global Top Targeted RNA Sequencing Players by Revenue (2021–2026)

3.1.2 Global Targeted RNA Sequencing Revenue Market Share by Players (2021–2026)

3.2 Global Top Targeted RNA Sequencing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Targeted RNA Sequencing Revenue

3.4 Global Targeted RNA Sequencing Market Concentration Ratio

3.4.1 Global Targeted RNA Sequencing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Targeted RNA Sequencing Revenue in 2025

3.5 Global Key Players of Targeted RNA Sequencing Head Offices and Areas Served

3.6 Global Key Players of Targeted RNA Sequencing, Products and Applications

3.7 Global Key Players of Targeted RNA Sequencing, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Targeted RNA Sequencing Breakdown Data by Type

4.1 Global Targeted RNA Sequencing Historic Market Size by Type (2021–2026)

4.2 Global Targeted RNA Sequencing Forecasted Market Size by Type (2027–2032)

5 Targeted RNA Sequencing Breakdown Data by Application

5.1 Global Targeted RNA Sequencing Historic Market Size by Application (2021–2026)

5.2 Global Targeted RNA Sequencing Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Targeted RNA Sequencing Market Size (2021–2032)

6.2 North America Targeted RNA Sequencing Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Targeted RNA Sequencing Market Size by Country (2021–2026)

6.4 North America Targeted RNA Sequencing Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Targeted RNA Sequencing Market Size (2021–2032)

7.2 Europe Targeted RNA Sequencing Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Targeted RNA Sequencing Market Size by Country (2021–2026)

7.4 Europe Targeted RNA Sequencing Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Targeted RNA Sequencing Market Size (2021–2032)

8.2 Asia-Pacific Targeted RNA Sequencing Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Targeted RNA Sequencing Market Size by Region (2021–2026)

8.4 Asia-Pacific Targeted RNA Sequencing Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Targeted RNA Sequencing Market Size (2021–2032)

9.2 Latin America Targeted RNA Sequencing Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Targeted RNA Sequencing Market Size by Country (2021–2026)

9.4 Latin America Targeted RNA Sequencing Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Targeted RNA Sequencing Market Size (2021–2032)

10.2 Middle East & Africa Targeted RNA Sequencing Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Targeted RNA Sequencing Market Size by Country (2021–2026)

10.4 Middle East & Africa Targeted RNA Sequencing Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Thermo Fisher

11.1.1 Thermo Fisher Company Details

11.1.2 Thermo Fisher Business Overview

11.1.3 Thermo Fisher Targeted RNA Sequencing Introduction

11.1.4 Thermo Fisher Revenue in Targeted RNA Sequencing Business (2021–2026)

11.1.5 Thermo Fisher Recent Development

11.2 Illumina

11.2.1 Illumina Company Details

11.2.2 Illumina Business Overview

11.2.3 Illumina Targeted RNA Sequencing Introduction

11.2.4 Illumina Revenue in Targeted RNA Sequencing Business (2021–2026)

11.2.5 Illumina Recent Development

11.3 Roche Holdings

11.3.1 Roche Holdings Company Details

11.3.2 Roche Holdings Business Overview

11.3.3 Roche Holdings Targeted RNA Sequencing Introduction

11.3.4 Roche Holdings Revenue in Targeted RNA Sequencing Business (2021–2026)

11.3.5 Roche Holdings Recent Development

11.4 BGI

11.4.1 BGI Company Details

11.4.2 BGI Business Overview

11.4.3 BGI Targeted RNA Sequencing Introduction

11.4.4 BGI Revenue in Targeted RNA Sequencing Business (2021–2026)

11.4.5 BGI Recent Development

11.5 Eurofins

11.5.1 Eurofins Company Details

11.5.2 Eurofins Business Overview

11.5.3 Eurofins Targeted RNA Sequencing Introduction

11.5.4 Eurofins Revenue in Targeted RNA Sequencing Business (2021–2026)

11.5.5 Eurofins Recent Development

11.6 LabCorp

11.6.1 LabCorp Company Details

11.6.2 LabCorp Business Overview

11.6.3 LabCorp Targeted RNA Sequencing Introduction

11.6.4 LabCorp Revenue in Targeted RNA Sequencing Business (2021–2026)

11.6.5 LabCorp Recent Development

11.7 Berry Genomics

11.7.1 Berry Genomics Company Details

11.7.2 Berry Genomics Business Overview

11.7.3 Berry Genomics Targeted RNA Sequencing Introduction

11.7.4 Berry Genomics Revenue in Targeted RNA Sequencing Business (2021–2026)

11.7.5 Berry Genomics Recent Development

11.8 Macrogen

11.8.1 Macrogen Company Details

11.8.2 Macrogen Business Overview

11.8.3 Macrogen Targeted RNA Sequencing Introduction

11.8.4 Macrogen Revenue in Targeted RNA Sequencing Business (2021–2026)

11.8.5 Macrogen Recent Development

11.9 GENEWIZ

11.9.1 GENEWIZ Company Details

11.9.2 GENEWIZ Business Overview

11.9.3 GENEWIZ Targeted RNA Sequencing Introduction

11.9.4 GENEWIZ Revenue in Targeted RNA Sequencing Business (2021–2026)

11.9.5 GENEWIZ Recent Development

11.10 Natera

11.10.1 Natera Company Details

11.10.2 Natera Business Overview

11.10.3 Natera Targeted RNA Sequencing Introduction

11.10.4 Natera Revenue in Targeted RNA Sequencing Business (2021–2026)

11.10.5 Natera Recent Development

11.11 Novogen

11.11.1 Novogen Company Details

11.11.2 Novogen Business Overview

11.11.3 Novogen Targeted RNA Sequencing Introduction

11.11.4 Novogen Revenue in Targeted RNA Sequencing Business (2021–2026)

11.11.5 Novogen Recent Development

11.12 Pacific Biosciences

11.12.1 Pacific Biosciences Company Details

11.12.2 Pacific Biosciences Business Overview

11.12.3 Pacific Biosciences Targeted RNA Sequencing Introduction

11.12.4 Pacific Biosciences Revenue in Targeted RNA Sequencing Business (2021–2026)

11.12.5 Pacific Biosciences Recent Development

11.13 Oxford Nanopore

11.13.1 Oxford Nanopore Company Details

11.13.2 Oxford Nanopore Business Overview

11.13.3 Oxford Nanopore Targeted RNA Sequencing Introduction

11.13.4 Oxford Nanopore Revenue in Targeted RNA Sequencing Business (2021–2026)

11.13.5 Oxford Nanopore Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Thermo Fisher

Illumina Inc

Roche Holdings

LabCorp

Berry Genomics

Macrogen

Genewiz

Eurofins

BGI

List of Tables

Table 1. Global Targeted RNA Sequencing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Exome Sequencing

Table 3. Key Players of Enrichment Sequencing

Table 4. Key Players of Amplicon Sequencing

Table 5. Global Targeted RNA Sequencing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Targeted RNA Sequencing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Targeted RNA Sequencing Market Size by Region (US$ Million), 2021–2026

Table 8. Global Targeted RNA Sequencing Market Share by Region (2021–2026)

Table 9. Global Targeted RNA Sequencing Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Targeted RNA Sequencing Market Share by Region (2027–2032)

Table 11. Targeted RNA Sequencing Market Trends

Table 12. Targeted RNA Sequencing Market Drivers

Table 13. Targeted RNA Sequencing Market Challenges

Table 14. Targeted RNA Sequencing Market Restraints

Table 15. Global Targeted RNA Sequencing Revenue by Players (US$ Million), 2021–2026

Table 16. Global Targeted RNA Sequencing Market Share by Players (2021–2026)

Table 17. Global Top Targeted RNA Sequencing Players by Tier (Tier 1, Tier 2, and Tier 3), based on Targeted RNA Sequencing Revenue, 2025

Table 18. Ranking of Global Top Targeted RNA Sequencing Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Targeted RNA Sequencing Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Targeted RNA Sequencing, Headquarters and Area Served

Table 21. Global Key Players of Targeted RNA Sequencing, Products and Applications

Table 22. Global Key Players of Targeted RNA Sequencing, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Targeted RNA Sequencing Market Size by Type (US$ Million), 2021–2026

Table 25. Global Targeted RNA Sequencing Revenue Market Share by Type (2021–2026)

Table 26. Global Targeted RNA Sequencing Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Targeted RNA Sequencing Revenue Market Share by Type (2027–2032)

Table 28. Global Targeted RNA Sequencing Market Size by Application (US$ Million), 2021–2026

Table 29. Global Targeted RNA Sequencing Revenue Market Share by Application (2021–2026)

Table 30. Global Targeted RNA Sequencing Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global Targeted RNA Sequencing Revenue Market Share by Application (2027–2032)

Table 32. North America Targeted RNA Sequencing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Targeted RNA Sequencing Market Size by Country (US$ Million), 2021–2026

Table 34. North America Targeted RNA Sequencing Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Targeted RNA Sequencing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Targeted RNA Sequencing Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Targeted RNA Sequencing Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Targeted RNA Sequencing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Targeted RNA Sequencing Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Targeted RNA Sequencing Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Targeted RNA Sequencing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Targeted RNA Sequencing Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Targeted RNA Sequencing Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Targeted RNA Sequencing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Targeted RNA Sequencing Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Targeted RNA Sequencing Market Size by Country (US$ Million), 2027–2032

Table 47. Thermo Fisher Company Details

Table 48. Thermo Fisher Business Overview

Table 49. Thermo Fisher Targeted RNA Sequencing Product

Table 50. Thermo Fisher Revenue in Targeted RNA Sequencing Business (US$ Million), 2021–2026

Table 51. Thermo Fisher Recent Development

Table 52. Illumina Company Details

Table 53. Illumina Business Overview

Table 54. Illumina Targeted RNA Sequencing Product

Table 55. Illumina Revenue in Targeted RNA Sequencing Business (US$ Million), 2021–2026

Table 56. Illumina Recent Development

Table 57. Roche Holdings Company Details

Table 58. Roche Holdings Business Overview

Table 59. Roche Holdings Targeted RNA Sequencing Product

Table 60. Roche Holdings Revenue in Targeted RNA Sequencing Business (US$ Million), 2021–2026

Table 61. Roche Holdings Recent Development

Table 62. BGI Company Details

Table 63. BGI Business Overview

Table 64. BGI Targeted RNA Sequencing Product

Table 65. BGI Revenue in Targeted RNA Sequencing Business (US$ Million), 2021–2026

Table 66. BGI Recent Development

Table 67. Eurofins Company Details

Table 68. Eurofins Business Overview

Table 69. Eurofins Targeted RNA Sequencing Product

Table 70. Eurofins Revenue in Targeted RNA Sequencing Business (US$ Million), 2021–2026

Table 71. Eurofins Recent Development

Table 72. LabCorp Company Details

Table 73. LabCorp Business Overview

Table 74. LabCorp Targeted RNA Sequencing Product

Table 75. LabCorp Revenue in Targeted RNA Sequencing Business (US$ Million), 2021–2026

Table 76. LabCorp Recent Development

Table 77. Berry Genomics Company Details

Table 78. Berry Genomics Business Overview

Table 79. Berry Genomics Targeted RNA Sequencing Product

Table 80. Berry Genomics Revenue in Targeted RNA Sequencing Business (US$ Million), 2021–2026

Table 81. Berry Genomics Recent Development

Table 82. Macrogen Company Details

Table 83. Macrogen Business Overview

Table 84. Macrogen Targeted RNA Sequencing Product

Table 85. Macrogen Revenue in Targeted RNA Sequencing Business (US$ Million), 2021–2026

Table 86. Macrogen Recent Development

Table 87. GENEWIZ Company Details

Table 88. GENEWIZ Business Overview

Table 89. GENEWIZ Targeted RNA Sequencing Product

Table 90. GENEWIZ Revenue in Targeted RNA Sequencing Business (US$ Million), 2021–2026

Table 91. GENEWIZ Recent Development

Table 92. Natera Company Details

Table 93. Natera Business Overview

Table 94. Natera Targeted RNA Sequencing Product

Table 95. Natera Revenue in Targeted RNA Sequencing Business (US$ Million), 2021–2026

Table 96. Natera Recent Development

Table 97. Novogen Company Details

Table 98. Novogen Business Overview

Table 99. Novogen Targeted RNA Sequencing Product

Table 100. Novogen Revenue in Targeted RNA Sequencing Business (US$ Million), 2021–2026

Table 101. Novogen Recent Development

Table 102. Pacific Biosciences Company Details

Table 103. Pacific Biosciences Business Overview

Table 104. Pacific Biosciences Targeted RNA Sequencing Product

Table 105. Pacific Biosciences Revenue in Targeted RNA Sequencing Business (US$ Million), 2021–2026

Table 106. Pacific Biosciences Recent Development

Table 107. Oxford Nanopore Company Details

Table 108. Oxford Nanopore Business Overview

Table 109. Oxford Nanopore Targeted RNA Sequencing Product

Table 110. Oxford Nanopore Revenue in Targeted RNA Sequencing Business (US$ Million), 2021–2026

Table 111. Oxford Nanopore Recent Development

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

Table 115. Authors List of This Report

List of Figures

Figure 1. Targeted RNA Sequencing Picture

Figure 2. Global Targeted RNA Sequencing Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Targeted RNA Sequencing Market Share by Type: 2025 vs 2032

Figure 4. Exome Sequencing Features

Figure 5. Enrichment Sequencing Features

Figure 6. Amplicon Sequencing Features

Figure 7. Global Targeted RNA Sequencing Market Size by Application (US$ Million), 2021–2032

Figure 8. Global Targeted RNA Sequencing Market Share by Application: 2025 vs 2032

Figure 9. Research Institutes Case Studies

Figure 10. Hospitals & Clinics Case Studies

Figure 11. Biotechnology Company Case Studies

Figure 12. Diagnostic Lab Case Studies

Figure 13. Targeted RNA Sequencing Report Years Considered

Figure 14. Global Targeted RNA Sequencing Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 15. Global Targeted RNA Sequencing Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global Targeted RNA Sequencing Market Share by Region: 2025 vs 2032

Figure 17. Global Targeted RNA Sequencing Market Share by Players in 2025

Figure 18. Global Targeted RNA Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Targeted RNA Sequencing Revenue in 2025

Figure 20. North America Targeted RNA Sequencing Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. North America Targeted RNA Sequencing Market Share by Country (2021–2032)

Figure 22. United States Targeted RNA Sequencing Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Canada Targeted RNA Sequencing Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Targeted RNA Sequencing Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Targeted RNA Sequencing Market Share by Country (2021–2032)

Figure 26. Germany Targeted RNA Sequencing Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. France Targeted RNA Sequencing Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. U.K. Targeted RNA Sequencing Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Italy Targeted RNA Sequencing Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Russia Targeted RNA Sequencing Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Ireland Targeted RNA Sequencing Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Targeted RNA Sequencing Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Targeted RNA Sequencing Market Share by Region (2021–2032)

Figure 34. China Targeted RNA Sequencing Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Japan Targeted RNA Sequencing Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. South Korea Targeted RNA Sequencing Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Southeast Asia Targeted RNA Sequencing Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. India Targeted RNA Sequencing Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Australia & New Zealand Targeted RNA Sequencing Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Targeted RNA Sequencing Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Targeted RNA Sequencing Market Share by Country (2021–2032)

Figure 42. Mexico Targeted RNA Sequencing Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Brazil Targeted RNA Sequencing Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Targeted RNA Sequencing Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Targeted RNA Sequencing Market Share by Country (2021–2032)

Figure 46. Israel Targeted RNA Sequencing Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Saudi Arabia Targeted RNA Sequencing Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. UAE Targeted RNA Sequencing Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Thermo Fisher Revenue Growth Rate in Targeted RNA Sequencing Business (2021–2026)

Figure 50. Illumina Revenue Growth Rate in Targeted RNA Sequencing Business (2021–2026)

Figure 51. Roche Holdings Revenue Growth Rate in Targeted RNA Sequencing Business (2021–2026)

Figure 52. BGI Revenue Growth Rate in Targeted RNA Sequencing Business (2021–2026)

Figure 53. Eurofins Revenue Growth Rate in Targeted RNA Sequencing Business (2021–2026)

Figure 54. LabCorp Revenue Growth Rate in Targeted RNA Sequencing Business (2021–2026)

Figure 55. Berry Genomics Revenue Growth Rate in Targeted RNA Sequencing Business (2021–2026)

Figure 56. Macrogen Revenue Growth Rate in Targeted RNA Sequencing Business (2021–2026)

Figure 57. GENEWIZ Revenue Growth Rate in Targeted RNA Sequencing Business (2021–2026)

Figure 58. Natera Revenue Growth Rate in Targeted RNA Sequencing Business (2021–2026)

Figure 59. Novogen Revenue Growth Rate in Targeted RNA Sequencing Business (2021–2026)

Figure 60. Pacific Biosciences Revenue Growth Rate in Targeted RNA Sequencing Business (2021–2026)

Figure 61. Oxford Nanopore Revenue Growth Rate in Targeted RNA Sequencing Business (2021–2026)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

mRNA Sequencing

Global RNA Sequencing Analysis Market Insights Forecast to 2030

Global RNA Sequencing Services Market Research Report 2024

Global Targeted DNA Sequencing Market Size Status and Forecast 2021 2027

Transcriptome Sequencing Based on RNA seq Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global NGS based RNA sequencing Market Insights Forecast to 2030

Global RNA Gene Expression Sequencing Market Research Report 2024

mRNA Transcriptome Sequencing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global RNA Sequencing Technologies Market Insights Forecast to 2030

Global Targeted Sequencing Market Research Report 2024

Global RNA Next Generation Sequencing Market Research Report 2024

Global Single Cell RNA Sequencing Market Research Report 2025

Global MicroRNA Sequencing miRNA Seq Market Research Report 2024

Global Targeted RNA Sequencing Kits Market Insights Forecast to 2030

Targeted Sequencing and Resequencing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Single Cell RNA Sequencing Solution Market Research Report 2024

Global Single cell Whole Transcriptome Sequencing Market Research Report 2024

RNA Analysis Transcriptomics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Whole Transcriptomics Sequencing Market Insights Forecast to 2030

Global Single Cell RNA Sequencing Kits Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions